Valiant Co

Valiant Co CapEx/OCF

The CapEx to Operating Cash Flow Ratio of Valiant Co (002643.SZ) as of Nov 19, 2026 is 63.63 %. In the previous year, CapEx to Operating Cash Flow Ratio was 101.11 % — a change of -37.07% (lower).

CapEx/OCF

63.63 %

YoY

-37.07%

Last updated:

CapEx to Operating Cash Flow Ratio of Valiant Co is 2025 63.63 % . CapEx to Operating Cash Flow Ratio of Valiant Co was 2024 101.11 % . It decreases by -37.07% lower compared to the previous year.

The Valiant Co CapEx/OCF history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

CapEx/OCF
Date
CapEx/OCF
Jan 1, 2018
126.93 CNY
Jan 1, 2019
112.65 CNY
Jan 1, 2020
117.99 CNY
Jan 1, 2021
70.02 CNY
Jan 1, 2022
131.74 CNY
Jan 1, 2023
128.78 CNY
Jan 1, 2024
101.11 CNY
Jan 1, 2025
63.63 CNY
The Valiant Co CapEx/OCF history
YEARCapEx/OCFYoY
63.63 %-37.07%
101.11 %-21.49%
128.78 %-2.24%
131.74 %+88.14%
70.02 %-40.65%
117.99 %+4.74%
112.65 %-11.25%
126.93 %+102.65%
62.63 %-78.48%
291.04 %+199.22%
97.27 %-26.39%
132.14 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valiant Co Stock analysis

What does Valiant Co do? Valiant Co., Ltd. generates revenue through three core business segments. The Information Materials Industry segment produces and sells display materials and functional materials, targeting customers in the electronics and manufacturing sectors. The Environmental Protection Materials Industry segment develops and manufactures new zeolite environmental protection materials for tail gas purification, serving automotive and industrial clients requiring emission control solutions. The Large Health Industry segment focuses on pharmaceutical production, life sciences, and in vitro diagnostic services, catering to healthcare providers and medical facilities. The company's products include display materials, functional materials, new zeolite environmental protection materials, pharmaceuticals, and in vitro diagnostic services. These offerings are sold across the three industry segments, with the Environmental Protection Materials segment specifically addressing tail gas purification needs. The Large Health Industry segment's in vitro diagnostic services support healthcare operations through specialized medical solutions. Valiant Co., Ltd. serves diverse customer segments including electronics manufacturers, automotive industries, industrial emission control clients, and healthcare providers. The firm's revenue streams are derived from the sale of physical products like display materials and zeolite materials, as well as service-based offerings in diagnostics and pharmaceuticals. The company's business model relies on manufacturing and selling these products across its three operational segments. Valiant Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Valiant Co stock

CapEx to Operating Cash Flow Ratio of Valiant Co is 63.63 % in 2025.

CapEx to Operating Cash Flow Ratio of Valiant Co changed from 101.11 % to 63.63 %, representing a -37.07% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of CapEx to Operating Cash Flow Ratio Valiant Co since 2006 – with annual values, charts, and detailed analysis.

The CapEx/OCF ratio shows what percentage of operating cash flow is reinvested in capital assets. Lower ratios indicate more free cash available for shareholders.

A 'good' varies by industry and company stage. On Eulerpool, you can compare CapEx to Operating Cash Flow Ratio's Valiant Co with sector peers and the industry average to assess whether it is attractive.

To evaluate CapEx to Operating Cash Flow Ratio's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for CapEx to Operating Cash Flow Ratio.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Valiant Co

All Key Metrics — Valiant Co